.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Dow
US Department of Justice
Cantor Fitzgerald
Mallinckrodt
Cipla
UBS
Queensland Health
Julphar
Chubb

Generated: November 23, 2017

DrugPatentWatch Database Preview

RUFINAMIDE Drug Profile

« Back to Dashboard

Which patents cover Rufinamide, and what generic Rufinamide alternatives are available?

Rufinamide is a drug marketed by Glenmark Pharms Ltd, West-ward Pharms Int, and Mylan Pharms Inc. and is included in three NDAs.

The generic ingredient in RUFINAMIDE is rufinamide. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the rufinamide profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd
RUFINAMIDE
rufinamide
TABLET;ORAL205075-001May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
RUFINAMIDE
rufinamide
TABLET;ORAL204988-002May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms Ltd
RUFINAMIDE
rufinamide
TABLET;ORAL205075-002May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
RUFINAMIDE
rufinamide
TABLET;ORAL204988-001May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
RUFINAMIDE
rufinamide
TABLET;ORAL205095-002May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
RUFINAMIDE
rufinamide
TABLET;ORAL205095-001May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Fuji
Julphar
Cipla
UBS
Novartis
Chinese Patent Office
Deloitte
Colorcon
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot